Kura Oncology Inc (FRA:KUR)
€ 16.55 -0.57 (-3.33%) Market Cap: 1.26 Bil Enterprise Value: 831.42 Mil PE Ratio: 0 PB Ratio: 3.03 GF Score: 36/100

Q3 2023 Kura Oncology Inc Earnings Call Transcript

Nov 02, 2023 / 08:30PM GMT
Release Date Price: €7.5 (-5.66%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Third Quarter 2023 Kura Oncology, Inc. Earnings Conference Call.

At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. (Operator Instructions) This call is being recorded on Thursday, November 2, 2023.

I would now like to turn over the call to Pete De Spain, Head of Investor Relations. Please go ahead.

Pete De Spain
Kura Oncology, Inc. - EVP of IR & Corporate Communications

Thank you, Lester. Good afternoon, and welcome to Kura Oncology's third quarter 2023 conference call.

Joining me on the call are Dr. Troy Wilson, our President and Chief Executive Officer; and Tom Doyle, our Senior Vice President of Finance and Accounting.

Before I turn the call over to Dr. Wilson, I'd like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and may involve risks and uncertainties that could cause

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot